NCT04766086
Despite preventive measures, group B strep infection continues to threaten the health of infants around the world. Your participation in a new research study could help us find a vaccine.
Group B strep (GBS) is a bacterium that causes a variety of infections, especially in pregnant women and infants. Although GBS infections may be relatively minor in adults, GBS can cause more serious illness in infants, including sepsis, meningitis, pneumonia, and death. This study is evaluating if an investigational GBS vaccine is safe and effective when administered alongside Tdap (tetanus, diptheria, pertussis) in healthy, nonpregnant women.
Who may participate
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
About Group B Strep
Group B strep (GBS) is a bacterium that causes a variety of infections, especially in pregnant women and infants. Although GBS infections may be relatively minor in adults, GBS can cause more serious illness in infants, including sepsis, meningitis, pneumonia, and death.
Currently, there are no approved vaccines to prevent Group B Strep.
About Vaccines
Vaccines have been a tried-and-true tool for preventing a variety of diseases for over 200 years. With your help, we can add Group B Strep vaccine to the list.